Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acne Vulgaris Therapy
Study data from Naval Medical Center, Dermatology Department update understanding of acne vulgaris therapy
April 13th, 2008
Current study results from the report, 'Treatment of acne scars using the plasma skin regeneration (PSR) system,' have been published. According to recent research from the United States, "Acne scarring is a common and difficult to treat condition. The plasma skin regeneration (PSR) system is a novel device that causes delayed ablation of the epidermis and controlled thermal modification to the underlying dermis." "PSR has previously been shown to be a safe and effective treatment for facial rhytides and benign skin lesions. In this study, we investigated the safety and efficacy of single-treatment, high-energy, double-pass PSR for the treatment of acne scarring....
Source: Pharma Investments, Ventures & Law Weekly (2008-04-13)
|
